United States High-Sensitivity Troponin Market Size By Type(High-Sensitivity Troponin I (hs-TnI), High-Sensitivity Troponin T(hs-TnT)), By Application(Myocardial Infarction, Acute Coronary Syndrome, Others) And Forecast
Report ID: 127410|No. of Pages: 202
United States High-Sensitivity Troponin Market Size By Type(High-Sensitivity Troponin I (hs-TnI), High-Sensitivity Troponin T(hs-TnT)), By Application(Myocardial Infarction, Acute Coronary Syndrome, Others) And Forecast
United States High-Sensitivity Troponin Market Size And Forecast
United States High-Sensitivity Troponin Market size was valued at USD 731.27 Million in 2024 and is projected to reach USD 1572.1 Million by 2031, growing at a CAGR of 10.04% from 2024 to 2031.
The United States High sensitivity troponin market is expected to drive the market growth due to the rising prevalence of cardiovascular diseases in the U.S. due to several factors such as smoking, obesity, diabetes, and lifestyle changes. The United States High-Sensitivity Troponin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
What is High-Sensitivity Troponin?
High sensitivity Troponin is the preferred biomarker for the diagnosis of acute myocardial infarction. Among the cardiac biomarker tests, troponin is the biomarker test of choice for detecting heart damage. This test is performed with a blood sample using a needle to draw blood from a vein in the hand or arm. Troponin is elevated within a few hours of heart damage and stays elevated up to two weeks. The test performed for some hours helps diagnose a heart attack. High sensitivity Troponin is categorized into two types such as troponin T and troponin I. High Sensitivity Troponin T (hs-TnT) is an independent prognostic marker that helps in the diagnosis of myocardial infarction (MI) in an acute setting, and there is literature supporting its use to assess relative risk for cardiovascular disease (CVD) and adverse cardiovascular events. Whereas, the high sensitivity troponin I (hsTnI) delivers high clinical sensitivity and specificity for diagnostic accuracy, high analytical sensitivity and precision for detecting small changes at the 99th percentile, and high negative predictive value for confidence in early rule out of acute myocardial infarction (AMI).
The United States High sensitivity troponin market is expected to drive the market growth due to the rising prevalence of cardiovascular diseases in the U.S. due to the several factors such as smoking, obesity, diabetes, and lifestyle changes. According to the American Heart Association around 2,300 Americans die of cardiovascular disease each day. The high sensitivity troponin helps in monitoring the prognosis of certain condition with greater accuracy and providing the most effective treatment to the patients. Therefore, with the growing concerns regarding cardiovascular disorders, the market is expected to grow over the forecast period. However, the lack of required precision for collecting samples and limited reimbursements by government and private insurance might restrict the market growth.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=127410
United States High-Sensitivity Troponin Market Overview
The rising prevalence of cardiovascular diseases in the U.S. due to the several factors such as smoking, obesity, diabetes, and lifestyle changes. According to the American Heart Association around 2,300 Americans die of cardiovascular disease each day. The high sensitivity Troponin helps in monitoring the prognosis of certain condition with greater accuracy and providing the most effective treatment to the patients Therefore, with the growing concerns regarding cardiovascular disorders, the market is expected to grow over the forecast period. Rising research and development on cardiovascular interventions and the introduction of rapid and novel biomarker tests is expected to foster the growth of the market during the forecast period. Key market players are investing in the research and development of novel biomarkers for the diagnosis and prognosis and predictive analysis of cardiovascular disorder.
The various epidemiology studies use cardiac biomarkers to investigate different stages of diseases in humans. It requires careful handling and storage of precious biological samples with the goal of obtaining a large amount of information from limited samples and reducing the future research costs with the use of banked samples. The sample collection is thus one of the key issues faced by service providers, followed by access to these samples. Likewise, the stringent quality control is also required for these samples, and they need to be stored under the right conditions to avoid any loss. The demand for point-of-care testing (POCT) assays has increased considerably, due to the globally increasing number of cardiovascular disease patients in emergency departments (EDs) requiring urgent disease diagnosis. The adoption of point-of-care testing with cardiac biomarkers is growing in diagnostic procedures for cardiovascular diseases across the globe, owing to the advantages offered by it.
United States High-Sensitivity Troponin Market Segmentation Analysis
The United States High-Sensitivity Troponin Market is segmented on the basis of Type And Application.
United States High-Sensitivity Troponin Market, By Type
- High-Sensitivity Troponin I (hs-TnI)
- High-Sensitivity Troponin T(hs-TnT)
Based on Type, the market is bifurcated into High-Sensitivity Troponin I (hs-TnI), High-Sensitivity Troponin T(hs-TnT). High-Sensitivity Troponin I (hs-TnI) accounted for the largest market share of 73.36% in 2019, and is projected to grow at the highest CAGR of 10.27% during the forecast period. The high sensitivity troponin I (hsTnI) holds the largest market share position. It delivers high clinical sensitivity and specificity for diagnostic accuracy, high analytical sensitivity and precision for detecting small changes at the 99th percentile, and high negative predictive value for confidence in early rule out of acute myocardial infarction (AMI).
United States High-Sensitivity Troponin Market, By Application
- Myocardial Infarction
- Acute Coronary Syndrome
- Others
To Get Summarized Market Report By Application:- Download Sample Report Now
On the basis of Application, the United States High-Sensitivity Troponin Market has been segmented into Myocardial Infarction, Acute Coronary Syndrome, Others. Acute Coronary Syndrome accounted for the largest market share of 68.27% in 2019, and is projected to grow at the highest CAGR of 10.38% during the forecast period. Acute Coronary Syndrome holds the largest market share during the forecast period. It is a condition associated with sudden, reduced blood flow to the heart. One such condition is a heart attack (myocardial infarction), when cell death results in damaged or destroyed heart tissue. Acute Coronary Syndrome (ACS) is expected to form the highest-grossing segment. This is due to the high ACS incidence poses an immense economic and social global burden.
Key Players
The “United States High-Sensitivity Troponin Market” study report will provide a valuable insight with an emphasis on the US market. The major players in the market are Roche Diagnostics (Roche Holding Ag), Abbott Laboratories, Siemens Healthineers Usa (Siemens Healthineers Ag), Beckman Coulter (Danaher Corporation).
The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
Company Name |
Key Developments |
Description |
|---|---|---|
| Roche Diagnostics | New Launch | • Roche Diagnostics launched the VITROS high-sensitivity Troponin I assay. |
| Roche Diagnostics | Approval | • FDA granted 510(k) clearance to Roche for its Elecsys Troponin T (TnT) Gen 5 Stat blood test as an aid in the diagnosis of acute myocardial infarction. • With this, Roche has become the first company in the U.S. to provide high-sensitivity cardiac troponin (hs-cTn) testing. |
| Siemens Healthineers | New Launch | • Siemens Healthineers announced the availability of its new high-sensitivity Troponin I (TNIH)1 in vitro diagnostics assay. • This is design to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac Troponin I in serum or plasma. |
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2021-2023 |
| Unit | Value (USD Million) |
| Key Companies Profiled | Roche Diagnostics (Roche Holding Ag), Abbott Laboratories, Siemens Healthineers Usa (Siemens Healthineers Ag), Beckman Coulter (Danaher Corporation). |
| Segments Covered |
|
| Customization scope | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research
To know more about the Research Methodology and other aspects of the research study, kindly Get in touch with our sales team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP DOWN APPROACH
2.1 RESEARCH FLOW
3 EXECUTIVE SUMMARY
3.1 MARKET OVERVIEW
3.2 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY TYPE (USD MILLION)
3.3 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY APPLICATION (USD MILLION)
3.4 FUTURE MARKET OPPORTUNITIES
3.5 UNITED STATES MARKET SPLIT
4 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET OUTLOOK
4.1 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET OUTLOOK
4.2 MARKET DRIVERS
4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES
4.2.2 INTRODUCTION OF NOVEL BIOMARKER TESTS
4.3 MARKET RESTRAINT
4.3.1 LACK OF REQUIRED PRECISION FOR COLLECTING SAMPLES AND LIMITED REIMBURSEMENTS BY GOVERNMENT AND PRIVATE INSURANCE
4.4 MARKET OPPORTUNITIES
4.4.1 INCREASING THE PREFERENCE FOR POINT-OF-CARE TESTING (POCT) WITH CARDIAC BIOMARKERS
4.5 IMPACT OF COVID – 19 ON HIGH-SENSITIVITY TROPONIN MARKET
5 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY TYPE
5.1 OVERVIEW
5.2 HIGH-SENSITIVITY TROPONIN I (HS-TNI)
5.3 HIGH-SENSITIVITY TROPONIN T (HS-TNT)
6 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 MYOCARDIAL INFARCTION
6.3 ACUTE CORONARY SYNDROME
6.4 OTHERS
7 COMPETITIVE LANDSCAPE
7.1 OVERVIEW
7.2 COMPETITIVE SCENARIO
7.3 COMPANY MARKET RANKING ANALYSIS
8 COMPANY PROFILES
8.1 ROCHE DIAGNOSTICS (ROCHE HOLDING AG)
8.1.1 COMPANY OVERVIEW
8.1.2 COMPANY INSIGHTS
8.1.3 SEGMENT BREAKDOWN
8.1.4 PRODUCT BENCHMARKING
8.1.5 KEY DEVELOPMENTS
8.1.6 SWOT ANALYSIS
8.2 ABBOTT LABORATORIES
8.2.1 COMPANY OVERVIEW
8.2.2 COMPANY INSIGHTS
8.2.3 SEGMENT BREAKDOWN
8.2.4 PRODUCT BENCHMARKING
8.2.5 KEY DEVELOPMENTS
8.2.6 SWOT ANALYSIS
8.3 SIEMENS HEALTHINEERS USA (SIEMENS HEALTHINEERS AG)
8.3.1 COMPANY OVERVIEW
8.3.2 COMPANY INSIGHTS
8.3.3 SEGMENT BREAKDOWN
8.3.4 PRODUCT BENCHMARKING
8.3.5 KEY DEVELOPMENTS
8.3.6 SWOT ANALYSIS
8.4 BECKMAN COULTER (DANAHER CORPORATION)
8.4.1 COMPANY OVERVIEW
8.4.2 COMPANY INSIGHTS
8.4.3 SEGMENT BREAKDOWN
8.4.4 PRODUCT BENCHMARKING
8.4.5 KEY DEVELOPMENTS
8.4.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 2 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 3 COMPANY MARKET RANKING ANALYSIS
TABLE 4 ROCHE DIAGNOSTICS (ROCHE HOLDING AG): PRODUCT BENCHMARKING
TABLE 5 ROCHE DIAGNOSTICS (ROCHE HOLDING AG): KEY DEVELOPMENTS
TABLE 6 ABBOTT LABORATORIES: PRODUCT BENCHMARKING
TABLE 7 ABBOTT LABORATORIES: KEY DEVELOPMENTS
TABLE 8 SIEMENS HEALTHINEERS USA (SIEMENS HEALTHINEERS AG): PRODUCT BENCHMARKING
TABLE 9 SIEMENS HEALTHINEERS USA (SIEMENS HEALTHINEERS AG): KEY DEVELOPMENTS
TABLE 10 BECKMAN COULTER (DANAHER CORPORATION): PRODUCT BENCHMARKING
TABLE 11 BECKMAN COULTER (DANAHER CORPORATION): KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET SEGMENTATION
FIGURE 2 RESEARCH TIMELINES
FIGURE 3 DATA TRIANGULATION
FIGURE 4 MARKET RESEARCH FLOW
FIGURE 5 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET OVERVIEW
FIGURE 6 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY TYPE (USD MILLION)
FIGURE 7 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY APPLICATION (USD MILLION)
FIGURE 8 FUTURE MARKET OPPORTUNITIES
FIGURE 9 EUROPE DOMINATED THE MARKET IN 2020
FIGURE 10 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET OUTLOOK
FIGURE 11 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY TYPE
FIGURE 12 UNITED STATES HIGH-SENSITIVITY TROPONIN MARKET, BY APPLICATION
FIGURE 13 KEY STRATEGIC DEVELOPMENTS
FIGURE 14 ROCHE HOLDING AG: COMPANY INSIGHT
FIGURE 15 ROCHE HOLDING AG: BREAKDOWN
FIGURE 16 ROCHE DIAGNOSTICS: SWOT ANALYSIS
FIGURE 17 ABBOTT LABORATORIES: COMPANY INSIGHT
FIGURE 18 ABBOTT LABORATORIES: BREAKDOWN
FIGURE 19 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 20 SIEMENS HEALTHINEERS AG: COMPANY INSIGHT
FIGURE 21 SIEMENS HEALTHINEERS AG: BREAKDOWN
FIGURE 22 SIEMENS DIAGNOSTICS (SIEMENS HEALTHINEERS AG): SWOT ANALYSIS
FIGURE 23 DANAHER CORPORATION: COMPANY INSIGHT
FIGURE 24 DANAHER CORPORATION: BREAKDOWN
FIGURE 25 BECKMAN COULTER (DANAHER CORPORATION): SWOT ANALYSIS
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
